Harrow, Inc. Earnings Per Share (Basic)
Harrow, Inc. (HROW) reported Earnings Per Share (Basic) of -$0.46 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Harrow, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.46, a 428.57% decline year-over-year.
- Harrow, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.74.
- Harrow, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.03.
- Harrow, Inc. earnings per share, basic for the quarter ending 2025-06-30 was $0.14.
- Harrow, Inc. earnings per share, basic for fiscal 2025 was -$0.14.
- Harrow, Inc. earnings per share, basic for fiscal 2024 was -$0.49.
- Harrow, Inc. earnings per share, basic for fiscal 2023 was -$0.75.
- Harrow, Inc. earnings per share, basic for fiscal 2022 was -$0.51.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.46 10-Q · filed 2026-08-10 | -$1.20 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | -$0.74 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$0.14 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $0.03 10-Q · filed 2025-11-10 | $0.16 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.32 10-Q · filed 2025-11-10 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-06-30 | $0.14 10-Q · filed 2026-08-10 | -$0.35 10-Q · filed 2026-08-10 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-03-31 | -$0.50 10-Q · filed 2026-05-11 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-05-11 |
| 2024-12-31 | $0.19 derived: net income ÷ weighted average shares · filed 2026-03-02 | $0.07 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.49 10-K · filed 2026-03-02 |
| 2024-09-30 | -$0.12 10-Q · filed 2025-11-10 | -$0.30 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$0.68 10-Q · filed 2025-11-10 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-03-02 |
| 2024-06-30 | -$0.18 10-Q · filed 2025-08-11 | -$0.56 10-Q · filed 2025-08-11 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-03-02 |
| 2024-03-31 | -$0.38 10-Q · filed 2025-05-08 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-03-02 |
| 2023-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.75 10-K · filed 2026-03-02 |
| 2023-09-30 | -$0.13 10-Q · filed 2024-11-14 | -$0.27 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.48 10-Q · filed 2024-11-14 | -$0.46 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-06-30 | -$0.14 10-Q · filed 2024-08-07 | -$0.36 10-Q · filed 2024-08-07 | -$0.33 derived: net income ÷ weighted average shares · filed 2024-08-07 | -$0.56 derived: net income ÷ weighted average shares · filed 2024-08-07 |
| 2023-03-31 | -$0.22 10-Q · filed 2024-05-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$0.42 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$0.65 derived: net income ÷ weighted average shares · filed 2024-05-13 |
| 2022-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$0.42 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$0.51 10-K · filed 2024-03-19 |
| 2022-09-30 | -$0.24 10-Q · filed 2023-11-13 | -$0.46 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.55 10-Q · filed 2023-11-13 | -$0.83 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.23 10-Q · filed 2023-08-09 | -$0.32 10-Q · filed 2023-08-09 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-08-09 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-08-09 |
| 2022-03-31 | -$0.09 10-Q · filed 2023-05-11 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$0.67 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-05-11 |
| 2021-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.58 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.69 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.69 10-K · filed 2023-03-23 |
| 2021-09-30 | -$0.31 10-Q · filed 2022-11-14 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.42 10-Q · filed 2022-11-14 | -$0.37 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-06-30 | -$0.11 10-Q · filed 2022-08-09 | -$0.10 10-Q · filed 2022-08-09 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-08-09 | $0.27 derived: net income ÷ weighted average shares · filed 2022-08-09 |
| 2021-03-31 | $0.01 10-Q · filed 2022-05-05 | $0.05 derived: net income ÷ weighted average shares · filed 2022-05-05 | $0.39 derived: net income ÷ weighted average shares · filed 2022-05-05 | $0.38 derived: net income ÷ weighted average shares · filed 2022-05-05 |
| 2020-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2022-03-10 | $0.38 derived: net income ÷ weighted average shares · filed 2022-03-10 | $0.37 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$0.13 10-K · filed 2021-03-08 |
| 2020-09-30 | $0.33 10-Q · filed 2021-11-09 | $0.32 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$0.17 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$0.01 10-Q · filed 2020-08-10 | -$0.51 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | -$0.50 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $0.01 10-K · filed 2021-03-08 | |||
| 2019-09-30 | -$0.45 10-Q · filed 2020-11-09 | -$0.10 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$0.09 10-Q · filed 2020-08-10 | $0.36 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.46 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $0.67 10-K · filed 2020-03-13 | |||
| 2018-06-30 | $0.12 10-Q · filed 2019-08-14 | -$0.05 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$0.17 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$0.60 10-K · filed 2019-03-12 | |||
| 2017-06-30 | $0.07 10-Q · filed 2018-08-06 | -$0.18 10-Q · filed 2018-08-06 | ||
| 2016-06-30 | -$0.35 10-Q · filed 2017-08-10 | -$0.77 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |